title: A novel use of reticulated hyaluronic acid (Healaflow) for hypotony eyes in patients with uveitis.
abstract: Persistent ocular hypotony is a complex and ongoing challenge faced in ophthalmology. It can result in early ocular phthisis and associated visual decline, pain and deformity. We present the first case series, in which repeated intracameral injections of highly reticulated hyaluronic acid (Healaflow) have successfully prevented the complications of ocular hypotony in the long term. We believe it is a viable management option that can bring about a significant improvement to the quality of life in this subgroup of patients while avoiding frequent intervention.
authors.affiliation: Birmingham Midlands Eye Centre, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
authors.forename: R E
authors.initials: RE
authors.lastname: Stead
authors.affiliation: Birmingham Midlands Eye Centre, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
authors.forename: Z
authors.initials: Z
authors.lastname: Juma
authors.affiliation: Birmingham Midlands Eye Centre, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
authors.forename: S
authors.initials: S
authors.lastname: Turner
authors.affiliation: Royal Stoke University Hospital, UHNM, Newcastle Road, Stoke-on-Trent, ST4 6QG, UK.
authors.forename: L D
authors.initials: LD
authors.lastname: Jones
authors.affiliation: Birmingham Midlands Eye Centre, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
authors.forename: V C T
authors.initials: VC
authors.lastname: Sung
mesh_terms: D000328:Adult; D000867:Anterior Chamber; D003432:Cross-Linking Reagents / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D015814:Ocular Hypotension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D013997:Time Factors; D014605:Uveitis / Q000150:complications* / Q000188:drug therapy; D055675:Viscosupplements / Q000008:administration & dosage; D014792:Visual Acuity; D055815:Young Adult
chemical_list: D003432:Cross-Linking Reagents; D055675:Viscosupplements; D006820:Hyaluronic Acid
keywords: Glaucoma; Intraocular pressure; Treatment other